Melbourne, Australia, July 18, 2014 --(PR.com
)-- An astonishing 5-10 million women worldwide are estimated to have breast implants. Despite advanced surgical techniques and implant structure, it is estimated that 20% of these women need to have their implants removed or revised within 10 years.
When women with prosthetic breast implants lie on their front the human tissue surrounding the implant is potentially damaged and can cause these women discomfort and pain.
Founder of MammaGard™, Dr. Paul Evans, explains that many women are suffering in silence in regards to this problem.
“Many women who undergo mastectomy, reconstruction and augmentation, as well as many ‘natural’ breasted women are unable to lay on their front. Through the use of this device we aim to give women the opportunity to lie on their front comfortably without pain and with a reduced loading of their breast structures.”
Comfort and protection
Studies published in peer-reviewed journals proved that the MammaGard™ significantly reduced pain, breast displacement and mechanical pressure on reconstructed and natural breasts when lying on their front. The women reported that the orthotic device improved overall comfort between 64-100%.
Reconstructed and augmented breast structures do not move the same way natural breasts do, and women with altered anatomical structures or painful natural breast structures need to be specifically considered and managed. MammaGard™ is scientifically proven to repeatedly and reliably reduce breast loading and displacement during a variety of activities, whether it be sleeping, lounging or even sun bathing.
Mammagard™ was founded in 2011 by Dr. Paul Evans. Evans is a Melbourne based accomplished Osteopath, Orthotist and Prosthetist. The MammaGard™ is now available for individuals and clinicians directly from our website. Individuals are recommended to consult with their qualified health practitioner about fittings before purchasing.
MammaGard™ has been recognized by qualified health practitioners and has received the following awards:
· FDA Approved - Truncal Othortosis
· TGA Approved - Truncal Breast Othortosis
· Design Registered
· Certified Medical Device
If you would like more information about this topic, please contact Paul Evans at +61 386828633 or email at firstname.lastname@example.org.